Publications by authors named "Benjamin A Teply"

Claim this Profile
C
Corrigendum to 'The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules' [Biomaterials Volume 29 Issue 9 (2008) 5825].
Benjamin A Teply, Rong Tong, Seok Y Jeong, Gaurav Luther, Ines Sherifi

Biomaterials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.
Harshraj Leuva, Mengxi Zhou, Benjamin A Teply, Yeun-Hee Anna Park, Carol Luhrs

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Daniel E Spratt, Sandy Srinivas, Nabil Adra, Bilawal Ahmed, Yi An, Benjamin A Teply

J Natl Compr Canc Netw· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer.
Sandra A Frimpong, Benjamin A Teply

Transl Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synovial Fluid in Checkpoint Inhibitor-Induced Inflammatory Arthritis.
Mary Katherine L Anderson, James P Fagerland, Samantha Kohn, Amy C Cannella, Benjamin A Teply

Oncology (Williston Park)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer.
Sakthivel Muniyan, Raghupathy Vengoji, Rama Krishna Nimmakayala, Parthasarathy Seshacharyulu, Balaji Perumalsamy, Benjamin A Teply

Cancer Lett· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal use, combinations, and sequencing of therapies in advanced prostate cancer.
Clayton K Oakley, Benjamin A Teply

Expert Rev Clin Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.
Mark N Stein, Ecaterina E Dumbrava, Benjamin A Teply, Usama S Gergis, Martin E Guiterrez

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
Catherine H Marshall, Benjamin A Teply, Jiayun Lu, Lia Oliveira, Hao Wang

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the genetic and epigenetic architecture of prostate cancer.
Sheeraz Un Nazir, Juhi Mishra, Shailendra Kumar Maurya, Negin Ziamiavaghi, Sanika Bodas, Benjamin A Teply

Adv Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis.
Burles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, Bridget McGuire, Kara Lombardo

Bladder Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Rhonda Bitting, Benjamin A Teply

J Natl Compr Canc Netw· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of Metastatic Non-Small Cell Lung Cancer during Hospitalization: Missed Opportunity for Optimal Supportive Care?
Shristi Upadhyay Banskota, Jonathan Q Trinh, Elizabeth Lyden, Conor Houlihan, Samia Asif, Benjamin A Teply

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of plasma NRP2 and VEGF-C levels with prostate cancer disease severity.
Sarah A Mullen, Dipanwita Das, Negin Ziamiavaghi, Robin High, Kaustubh Datta, Benjamin A Teply

Prostate· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression.
Massar Alsamraae, Diane Costanzo-Garvey, Benjamin A Teply, Shawna Boyle, Gary Sommerville

Cancer Lett· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas, Benjamin A Teply

J Natl Compr Canc Netw· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer.
Heidi M Vieira, David P Kasper, Runqiu Wang, Lynette M Smith, Charles A Enke, Benjamin A Teply

Radiat Oncol J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of metastatic adenoid cystic (basal cell) carcinoma of the prostate: Systemic therapy for a rare disease.
Jonathan Q Trinh, Subodh M Lele, Benjamin A Teply

Prostate· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas, Benjamin A Teply

J Natl Compr Canc Netw· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinations.
Benjamin A Teply, Emmanuel S Antonarakis

Expert Rev Clin Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance.
Ridwan Islam, Juhi Mishra, Navatha Shree Polavaram, Sreyashi Bhattacharya, Zhengdong Hong, Benjamin A Teply

Cell Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Proton Pump Inhibitor Use on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Cancer Patients.
Kangning Peng, Ken Chen, Benjamin A Teply, Gary C Yee, Paraskevi A Farazi

Ann Pharmacother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid Tumors.
Mridula Krishnan, Pooja Kasinath, Robin High, Fang Yu, Benjamin A Teply

JCO Oncol Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
Linda My Huynh, Benjamin T Bonebrake, Dominick J DiMaio, Michael J Baine, Benjamin A Teply

Medicine (Baltimore)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for Treatment Response in Advanced Prostate Cancer.
Samia Asif, Benjamin A Teply

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis